Generic drug: sertaconazole nitrate
Brand name: Ertaczo
What is Ertaczo (sertaconazole nitrate), and how does it work?
Ertaczo is a prescription medicine used to treat the symptoms of Athlete's foot (Tinea Pedis). Ertaczo may be used alone or with other medications.
Ertaczo belongs to a class of drugs called Antifungals, Topical.
It is not known if Ertaczo is safe and effective in children younger than 12 years of age.
What are the side effects of Ertaczo?
Common side effects of Ertaczo include:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- severe burning, redness, or stinging after applying the medicine,
- itching or blistering skin, and
- swelling or oozing from the skin
Get medical help right away, if you have any of the symptoms listed above.
The most common side effects of Ertaczo include:
- dryness of treated skin,
- skin tenderness, and
- mild rash or skin irritation where the medication was applied
Tell the doctor if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Ertaczo. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the dosage for Ertaczo?
- Apply Ertaczo cream, 2% twice daily for 4 weeks. Apply a sufficient amount of
Ertaczo cream, 2% to cover both the affected areas between the toes and the immediately surrounding healthy skin. - Use
Ertaczo cream, 2% for the full treatment time recommended by the physician, even though symptoms may have improved. - Dry the affected area(s) thoroughly before application, if using
Ertaczo cream, 2% after bathing. - Wash hands after use.
- Avoid the use of occlusive dressings or wrappings.
- For topical use.
- Not for ophthalmic, oral, or intravaginal use.
What drugs interact with Ertaczo?
No Information provided
Is Ertaczo safe to use while pregnant or breastfeeding?
- There are no available data on Ertaczo cream, 2% use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.
- There are no data available on the presence of sertaconazole in human or animal milk, its effects on the breastfed infant, or its effects on milk production.
- The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for
Ertaczo cream, 2% and any potential adverse effects on the breastfed infant from
Ertaczo cream, 2% or from the underlying maternal condition.